Paying user area
Try for free
Abiomed Inc. pages available for free this week:
- Cash Flow Statement
- Common-Size Balance Sheet: Assets
- Analysis of Liquidity Ratios
- Analysis of Solvency Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Enterprise Value to EBITDA (EV/EBITDA)
- Enterprise Value to FCFF (EV/FCFF)
- Price to Book Value (P/BV) since 2005
- Analysis of Revenues
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abiomed Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Operating profit margin | = | 100 | × | Income (loss) from operations1 | ÷ | Revenue1 | |
---|---|---|---|---|---|---|---|
Mar 31, 2022 | = | 100 | × | ÷ | |||
Mar 31, 2021 | = | 100 | × | ÷ | |||
Mar 31, 2020 | = | 100 | × | ÷ | |||
Mar 31, 2019 | = | 100 | × | ÷ | |||
Mar 31, 2018 | = | 100 | × | ÷ | |||
Mar 31, 2017 | = | 100 | × | ÷ | |||
Mar 31, 2016 | = | 100 | × | ÷ | |||
Mar 31, 2015 | = | 100 | × | ÷ | |||
Mar 31, 2014 | = | 100 | × | ÷ | |||
Mar 31, 2013 | = | 100 | × | ÷ | |||
Mar 31, 2012 | = | 100 | × | ÷ | |||
Mar 31, 2011 | = | 100 | × | ÷ | |||
Mar 31, 2010 | = | 100 | × | ÷ | |||
Mar 31, 2009 | = | 100 | × | ÷ | |||
Mar 31, 2008 | = | 100 | × | ÷ | |||
Mar 31, 2007 | = | 100 | × | ÷ | |||
Mar 31, 2006 | = | 100 | × | ÷ | |||
Mar 31, 2005 | = | 100 | × | ÷ |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
1 US$ in thousands
- Income (loss) from operations
- The operational income exhibits considerable variability over the observed period. Initially, the company experienced consistent operational losses from 2005 through 2010, with figures worsening up to a loss of approximately $30.3 million in 2006. From 2011 onwards, a notable turnaround occurs, with the company generating positive operating income beginning in 2012. This positive trend continues sharply, peaking at around $249.2 million in 2020, before slightly declining to approximately $140.7 million by 2022. Overall, the data reflects a transition from sustained losses toward solid operational profitability in later years.
- Revenue
- Revenue has shown steady and substantial growth throughout the time frame. Starting at about $38.2 million in 2005, the revenue increased almost continuously year-over-year, reaching over $1 billion by 2022. This growth is particularly pronounced from 2012 onwards, during which annual revenue more than quadrupled, indicating strong top-line expansion and possibly market penetration or product/service growth.
- Operating profit margin
- The operating profit margin mirrors the trends seen in operational income. Initially negative for many years—reaching its lowest point at nearly -69.4% in 2006—the margin starts to improve around 2011. Margins then become positive by 2012 and continue to increase, peaking above 29% in 2020 and 2021. However, a decline to approximately 13.6% by 2022 is observed, suggesting either increased operational costs or other factors impacting profitability. Despite the recent decline, the margin performance post-2011 indicates a marked improvement in operational efficiency and profitability relative to revenue.
Comparison to Competitors
Abiomed Inc. | Abbott Laboratories | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
---|---|---|---|---|---|
Mar 31, 2022 | |||||
Mar 31, 2021 | |||||
Mar 31, 2020 | |||||
Mar 31, 2019 | |||||
Mar 31, 2018 | |||||
Mar 31, 2017 | |||||
Mar 31, 2016 | |||||
Mar 31, 2015 | |||||
Mar 31, 2014 | |||||
Mar 31, 2013 | |||||
Mar 31, 2012 | |||||
Mar 31, 2011 | |||||
Mar 31, 2010 | |||||
Mar 31, 2009 | |||||
Mar 31, 2008 | |||||
Mar 31, 2007 | |||||
Mar 31, 2006 | |||||
Mar 31, 2005 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).